ISSN 2097-5724 CN 61-1535/R 主管·主办:陕西省疾病预防控制中心
疾病预防与控制 Disease Prevention and Control 医学学术期刊 双月刊
2026-04-048 检验与方法 2026, 2(04): 189-192

风险矩阵法在静脉用药调配中心肠外营养液配制中的价值

甘肃医学院附属医院

30下载次数 0被引频次 27阅读次数 10参考文献
知网阅读全文
摘要

目的 探讨风险矩阵法在静脉用药调配中心(PIVAS)肠外营养液配制流程中的优化应用效果。方法 选取2024年1月至2025年6月我院PIVAS肠外营养液配制处方作为研究对象,其中2024年1至6月采用常规流程管理作为对照组,2024年7月至2025年6月实施风险矩阵法优化流程管理作为观察组,均抽取6 000份处方与50个风险点调查。比较两组在配制不合格率、风险事件发生率、风险等级分布及配制效率方面的差异。结果 观察组肠外营养液配制不合格率显著低于对照组,高风险等级(E、H级)占比更低,高风险事件发生率明显下降,配制效率显著提升,与对照组的差异均具有统计学意义(P<0.05)。结论 风险矩阵法能有效优化PIVAS肠外营养液配制流程,降低配制风险,提升用药安全性和工作效率。

Abstract

Objective To investigate the effectiveness of risk matrix method in optimizing parenteral nutrition solution preparation processes at pharmacy intravenous admixture service(PIVAS). Methods This study analyzed prescription data from January 2024 to June 2025 at our hospital's PIVAS. The control group used conventional process management from January to June 2024, while the observation group implemented risk matrix method optimization from July 2024 to June 2025. A total of 6,000 prescriptions and 50 risk points were sampled for each group. Comparative analysis was conducted on preparation nonconformity rate, risk event occurrence rate, risk level distribution, and preparation efficiency between the two groups. Results The observation group demonstrated significantly lower preparation nonconformity rates than the control group, reduced proportions of high-risk levels(E and H grades), decreased high-risk event occurrences, and improved preparation efficiency—all statistically significant(P<0.05). Conclusion The risk matrix method effectively optimizes parenteral nutrition solution preparation processes in PIVAS, reduces preparation risks, and enhances medication safety and operational efficiency.

引用本文

按标准格式复制,或导出到文献管理软件
[1]张亚玲.风险矩阵法在静脉用药调配中心肠外营养液配制中的价值[J].疾病预防与控制,2026,2(04):189-192.